1.36CHF
376.87 MCHF
2.23 BCHF
349.68 M
About NOVOZYMES
Sector
CEO
Ester Baiget
Headquarters
Lyngby
Website
Employees (FY)
6.76 K
ISIN
DK0060336014
FIGI
BBG006TLSNH9
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NZYMB is 44.68 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange NOVOZYMES stocks are traded under the ticker NZYMB.
NOVOZYMES is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
NZYMB stock is 0% volatile and has beta coefficient of 0.36. Check out the list of the most volatile stocks — is NOVOZYMES there?
One year price forecast for NOVOZYMES has a max estimate of 65.00 CHF and a min estimate of 45.50 CHF.
NZYMB earnings for the last quarter are 0.44 CHF per share, whereas the estimation was 0.37 CHF resulting in a 16.84% surprise. The estimated earnings for the next quarter are 0.40 CHF per share. See more details about NOVOZYMES earnings.
NOVOZYMES revenue for the last quarter amounts to 576.84 M CHF despite the estimated figure of 570.50 M CHF. In the next quarter revenue is expected to reach 575.65 M CHF.
Yes, you can track NOVOZYMES financials in yearly and quarterly reports right on TradingView.
NZYMB net income for the last quarter is 86.99 M CHF, while the quarter before that showed 121.17 M CHF of net income which accounts for −28.21% change. Track more NOVOZYMES financial stats to get the full picture.
Today NOVOZYMES has the market capitalization of 23.09 B, it has decreased by 6.53% over the last week.
NOVOZYMES dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NZYMB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVOZYMES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 6.76 K employees. See our rating of the largest employees — is NOVOZYMES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVOZYMES technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVOZYMES stock shows the sell signal. See more of NOVOZYMES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVOZYMES future price: according to them, NZYMB price has a max estimate of 65.00 CHF and a min estimate of 45.50 CHF. Read a more detailed NOVOZYMES forecast: see what analysts think of NOVOZYMES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVOZYMES EBITDA is 727.07 M CHF, and current EBITDA margin is 32.72%. See more stats in NOVOZYMES financial statements.